Tyrosine kinase inhibitors (TKIs) have dramatically improved survival for patients with chronic myeloid leukemia (CML). No overall survival differences were observed between patients initiating first- ...

Comparative effectiveness research has been the target of recurrent criticism in some political circles, with opponents claiming it’s the “gateway to rationing” or it encourages “cookbook medicine.” ...

A study of the healthcare systems of the United Kingdom, Australia, Canada and Germany concludes that if implemented correctly, comparative effectiveness has the potential to improve care and reduce ...

The complexity of glycemic management in type 2 diabetes mellitus (T2DM) has increased dramatically in the past 15 years. In 1995, the drugs available for treatment of T2DM were insulin and ...

WASHINGTON--(BUSINESS WIRE)-- The Partnership to Improve Patient Care (PIPC) today hosted “Delivering on Patient-Centered CER” a forum that focused on the next steps in achieving patient-centered ...

Comparing the effectiveness of various drugs, treatments and devices will be the key to reigning in out-of-control healthcare costs, according to top healthcare leaders who spoke Dec. 4 at the eHealth ...

Penny Mohr, MA, senior program officer for improving healthcare systems at the Patient-Centered Outcomes Research Institute, discusses comparative effectiveness research, healthcare disparities, and ...

WASHINGTON--(BUSINESS WIRE)-- The Partnership to Improve Patient Care (PIPC) today launched the CER Inventory, an online research tool that gives researchers, providers and patients comprehensive ...

Editor’s note: This post is part of a Health Affairs Blog series titled “ORBITA: Lessons From A Landmark Trial," which focuses on the recent study finding that coronary stenting did not improve ...

Comparative effectiveness research in rheumatoid arthritis (RA) that is based on administrative databases rather than electronic health records or registries is a new research frontier The strengths ...

With the Patient Protection and Affordable Care Act ("ACA") set to dramatically increase access to medical care, the problem of rising costs will move center stage in health law and policy discussions ...

Show More 1 Division of Pharmaceutical Outcomes and Policy, University of North Carolina (UNC) Eshelman School of Pharmacy, Chapel Hill, NC Eligible patients had one or more fills for imatinib, ...